Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationGranulocyte Colony-Stimulating FactorTransplantation ConditioningTransplantation, HomologousLeukapheresisMelphalanAntigens, CD34Blood Component RemovalHematologic NeoplasmsCombined Modality TherapyHematopoietic Stem CellsCyclophosphamideStem Cell TransplantationMultiple MyelomaGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsBusulfanMyeloablative AgonistsBone Marrow TransplantationGraft SurvivalTreatment OutcomeStem CellsLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceHematopoiesisIfosfamideGranulocytesCarmustineCord Blood Stem Cell TransplantationCytophagocytosisSalvage TherapyVincristineAmyloidosisCytarabineTissue DonorsTransplantation ChimeraDisease-Free SurvivalHodgkin DiseaseRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationRecombinant ProteinsInfectionHistocompatibilityBlood Cell CountBlood CellsPlatelet CountTime FactorsPOEMS SyndromeSurvival AnalysisDoxorubicinHistocompatibility TestingLymphoma, T-CellImmunosuppressive AgentsVidarabineTransplantation, IsogeneicLeukemia, Myeloid, AcuteCarboplatinBone Marrow PurgingLeukemiaPrednisoneLeukocyte CountBone MarrowDexamethasoneLymphomaFollow-Up StudiesNeutropeniaCytomegalovirus InfectionsFeasibility StudiesAntineoplastic AgentsProspective StudiesImmunophenotypingGraft vs Leukemia EffectBone Marrow CellsFatal OutcomeAnemia, AplasticBlood DonorsLeukocytes, MononuclearMyelodysplastic SyndromesGranulocyte-Macrophage Colony-Stimulating FactorLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell SeparationColony-Forming Units AssayLymphocyte DepletionT-LymphocytesCells, CulturedHematologic DiseasesHistiocytosis, Non-Langerhans-CellEmbryonic Stem CellsFlow CytometryBone Marrow DiseasesImmunomagnetic Separation